medroxyprogesterone has been researched along with Hyperplasia in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (90.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CRAIG, JM; KISTNER, RW; STEINER, GJ | 1 |
Kear, M; Thornton, DA | 1 |
MacLaughlin, DT; Richardson, GS | 1 |
Cohen, CJ; Deppe, G | 1 |
Beard, RJ; Campbell, S; McQueen, J; Minardi, J; Whitehead, MI | 1 |
Coleman, ME; Feenstra, ES; Frank, DW; Gilbertson, TJ; Kimball, FA; Kirton, KT; Murchison, TE; Quinlan, WJ | 1 |
Braly, PS; Feldesman, MR; Gosink, BB; Lin, MC; Pretorius, DH; Stuenkel, CA; Wolf, SI | 1 |
Charreau, EH; Lanari, C; Molinolo, AA; Pasqualini, CD; Sanjuan, N | 1 |
Barnhill, D; Dames, J; Gallup, D; Heller, P; Hoskins, W; Park, R | 1 |
Ferenczy, A; Richart, RM | 1 |
2 review(s) available for medroxyprogesterone and Hyperplasia
Article | Year |
---|---|
Endometrial thickness after menopause: effect of hormone replacement.
Topics: Biopsy; Dilatation and Curettage; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Hyperplasia; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Time Factors; Ultrasonography | 1991 |
Endometrial morphologic response to hormonal environment.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma in Situ; Cell Transformation, Neoplastic; Endometrium; Epithelium; Estradiol; Estrogens; Female; Humans; Hyperplasia; Male; Medroxyprogesterone; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mucous Membrane; Ovulation; Progesterone Congeners; Ribosomes; Uterine Neoplasms | 1974 |
8 other study(ies) available for medroxyprogesterone and Hyperplasia
Article | Year |
---|---|
HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
Topics: Carcinoma in Situ; Drug Therapy; Endometrial Hyperplasia; Endometrium; Female; Geriatrics; Humans; Hydroxyprogesterones; Hyperplasia; Hysterectomy; Medroxyprogesterone; Menopause; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Pathology; Progestins; Uterine Neoplasms | 1963 |
Uterine cystic hyperplasia in a siamese Cat following treatment with medroxyprogesterone.
Topics: Animals; Cat Diseases; Cats; Cysts; Female; Hyperplasia; Medroxyprogesterone; Uterine Diseases | 1967 |
Progesterone binding by normal and abnormal human endometrium.
Topics: Adenocarcinoma; Binding, Competitive; Carcinoma, Squamous Cell; Cytosol; Endometrium; Female; Humans; Hydrocortisone; Hyperplasia; Kinetics; Medroxyprogesterone; Muscle Proteins; Progesterone; Protein Binding; Receptors, Cell Surface; Uterine Neoplasms | 1976 |
Endometrial carcinoma and oral contraceptive agents.
Topics: Adenocarcinoma; Adult; Contraceptives, Oral; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Dimethisterone; Drug Combinations; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Hyperplasia; Medroxyprogesterone; Middle Aged; Norgestrel; Time Factors; Uterine Neoplasms | 1977 |
The effects of cyclical oestrogen therapy and sequential oestrogen/progestogen therapy on the endometrium of postmenopausal women.
Topics: Endometrium; Estrogens; Female; Follow-Up Studies; Humans; Hyperplasia; Medroxyprogesterone; Menopause; Norethindrone; Uterine Hemorrhage; Uterine Neoplasms; Vacuum Curettage | 1977 |
Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years.
Topics: Adenoma; Animals; Dogs; Dose-Response Relationship, Drug; Estradiol; Female; Growth Hormone; Hormones; Hydrocortisone; Hyperplasia; Insulin; Mammary Glands, Animal; Medroxyprogesterone; Neoplasms; Progesterone; Prolactin; Thyrotropin; Time Factors; Triiodothyronine | 1979 |
Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors.
Topics: Adenocarcinoma; Animals; Delayed-Action Preparations; ErbB Receptors; Female; Hyperplasia; Immunohistochemistry; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Prolactin | 1987 |
Persistence of endometrial activity after radiation therapy for cervical carcinoma.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Dilatation and Curettage; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Hyperplasia; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Radiotherapy; Radiotherapy Dosage; Risk; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms | 1985 |